27 | Pharmaceutical PreparationsIBA
11/2014
-
01/2002 |
15 | Proteins (Proteins, Gene)FDA Link
04/2015
-
02/2002 |
9 | 7-hydroxystaurosporine (UCN 01)IBA
10/2013
-
11/2002 |
8 | NSC 680410IBA
12/2006
-
01/2002 |
7 | Antineoplastic Agents (Antineoplastics)IBA
01/2017
-
01/2002 |
7 | Cyclin-Dependent Kinases (cdk Proteins)IBA
10/2013
-
01/2002 |
7 | entinostat (MS 275)IBA
04/2007
-
02/2002 |
6 | tanespimycin (17AAG)IBA
07/2010
-
09/2003 |
6 | alvocidib (flavopiridol)IBA
01/2005
-
05/2002 |
5 | Tyrosine Kinase InhibitorsIBA
01/2019
-
12/2002 |
5 | perifosineIBA
11/2014
-
03/2002 |
5 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2007
-
12/2002 |
5 | Messenger RNA (mRNA)IBA
07/2006
-
09/2003 |
5 | 2- (4- amino- 3- methylphenyl)- 5- fluorobenzothiazoleIBA
07/2006
-
02/2002 |
5 | Phosphotransferases (Kinase)IBA
11/2005
-
01/2002 |
4 | DNA (Deoxyribonucleic Acid)IBA
05/2017
-
09/2004 |
4 | Folic Acid (Vitamin M)FDA LinkGeneric
12/2013
-
12/2009 |
4 | EC145IBA
12/2013
-
12/2009 |
4 | Histone Deacetylase InhibitorsIBA
04/2007
-
01/2005 |
4 | tyrphostin AG957IBA
12/2006
-
12/2002 |
4 | Cytochrome P-450 CYP1A1 (CYP1A1)IBA
07/2006
-
12/2003 |
3 | Asparaginase (Elspar)FDA Link
01/2020
-
05/2014 |
3 | NaphthoquinonesIBA
01/2017
-
01/2016 |
3 | Biomarkers (Surrogate Marker)IBA
05/2013
-
11/2002 |
3 | AlkaloidsIBA
11/2012
-
12/2009 |
3 | Imatinib Mesylate (Gleevec)FDA Link
07/2011
-
01/2002 |
3 | Cytarabine (Cytosar-U)FDA LinkGeneric
03/2009
-
12/2002 |
3 | benzothiazoleIBA
07/2006
-
01/2002 |
3 | 17- (dimethylaminoethylamino)- 17- demethoxygeldanamycinIBA
12/2005
-
08/2005 |
3 | Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
02/2005
-
01/2002 |
3 | Complementary DNA (cDNA)IBA
02/2004
-
03/2003 |
3 | Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2003
-
02/2002 |
2 | blinatumomabIBA
01/2019
-
01/2019 |
2 | Glutamine (L-Glutamine)FDA Link
01/2018
-
05/2014 |
2 | ErbB Receptors (EGF Receptor)IBA
04/2016
-
09/2007 |
2 | Reactive Oxygen Species (Oxygen Radicals)IBA
01/2016
-
12/2003 |
2 | Proteasome InhibitorsIBA
10/2013
-
12/2005 |
2 | Proteasome Endopeptidase Complex (Proteasome)IBA
10/2013
-
12/2005 |
2 | LigandsIBA
11/2012
-
01/2006 |
2 | HydrazinesIBA
11/2012
-
12/2009 |
2 | Insulin (Novolin)FDA Link
01/2010
-
11/2004 |
2 | Integrin beta3 (GPIIIa)IBA
11/2009
-
06/2009 |
2 | arginyl-glycyl-aspartic acidIBA
11/2009
-
06/2009 |
2 | Heat-Shock Proteins (Heat-Shock Protein)IBA
11/2009
-
09/2003 |
2 | geldanamycinIBA
11/2009
-
06/2009 |
2 | N-(2-hydroxypropyl)methacrylamideIBA
11/2009
-
06/2009 |
2 | hydroxypropyl methacrylateIBA
11/2009
-
06/2009 |
2 | Drug CombinationsIBA
03/2009
-
10/2003 |
2 | Monoclonal AntibodiesIBA
09/2007
-
11/2003 |
2 | G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
08/2006
-
04/2004 |
2 | Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
07/2006
-
02/2002 |
2 | Peptides (Polypeptides)IBA
01/2006
-
10/2004 |
2 | NF-kappa B (NF-kB)IBA
12/2005
-
02/2005 |
2 | Biological ProductsIBA
11/2005
-
07/2004 |
2 | Cyclin D1IBA
08/2005
-
05/2002 |
2 | NSC 674495IBA
12/2004
-
01/2002 |
2 | 1,1'- ((propane- 1,3- diyl)dioxy)bis(7- methoxy- 2- methylidene- 1,2,3,10,11,11a- hexahydro- 5H- pyrrolo(2,1- c)(1,4)benzodiazepin- 5,11- dione)IBA
09/2004
-
09/2004 |
2 | Cisplatin (Platino)FDA LinkGeneric
09/2004
-
07/2004 |
2 | ElementsIBA
06/2004
-
08/2002 |
2 | Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
02/2004
-
09/2003 |
2 | CaspasesIBA
02/2004
-
09/2003 |
2 | AntibodiesIBA
11/2003
-
06/2003 |
2 | Protein Kinase CIBA
09/2003
-
11/2002 |
1 | pegaspargase (Oncaspar)FDA Link
01/2020 |
1 | ponatinibIBA
01/2019 |